Tony Baxter

Presidente presso DName-iT NV

Health Technology

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
David Davies	M	-	DName-iT NV DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.	-
Harry Cuppens	M	-	DName-iT NV DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.	10 anni
Ilian Iliev	M	48	DName-iT NV DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.	-
Charles Maria Jonscher	M	70	DName-iT NV DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.	-
Don Daley	M	-	DName-iT NV DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.	-